Cipla gets nod to import Moderna vaccine in India
First Published: 29th June, 2021 18:46 IST
Mumbai-based pharmaceutical multinational Cipla on Tuesday received approval from the country’s drugs regulator to import the COVID-19 vaccine developed by US pharma major Moderna Inc. for restricted emergency use. This
Mumbai-based pharmaceutical multinational Cipla on Tuesday received approval from the country’s drugs regulator to import the COVID-19 vaccine developed by US pharma major Moderna Inc. for restricted emergency use. This will be the fourth vaccine for India.
Niti Aayog member (Health) VK Paul said new drug permission for restricted use has been granted for Moderna’s vaccine which gives a clear possibility of this vaccine being imported into India.
The company had sought Drugs Controller General of India (DCGI) nod for importing Moderna’s coronavirus vaccine.
Cipla filed an application on June 28 seeking permission to import the Moderna vaccine, referring to DCGI notices dated April 15 and June 1 stating that if a vaccine is approved by the USFDA for EUA, it can be granted marketing authorisation without bridging trial and assessment of safety data of first 100 beneficiaries of vaccines shall be submitted before rolling out an immunisation programme.
Moderna has also informed that the US government has agreed to donate to India a certain number of doses of the Moderna vaccine through COVAX and has sought approval from the Central Drugs Standard Control Organisation (CDSCO) for these vaccines.
Moderna’s method to protect against Covid-19 relies on messenger RNA (mRNA) to program cells to generate immunity to the coronavirus.
Several foreign vaccine makers such as Pfizer and Moderna have demanded an indemnity bond that will exempt them from legal claims in case there are any adverse effects from the vaccines when administered in India.
COMMENTS
TOPMOST STORY NOW
Live Meghalaya petrol bomb attacks: Asked DGP to ensure such incidents do not repeat, says Dy CM Prestone Tynsong
01st May 2024Live Petrol bombs the new weapon of violence in Meghalaya?
01st May 2024Live PMEAC Member Sanjeev Sanyal delivers Prof Sarat Mahanta Memorial Lecture in Guwahati
01st May 2024Live Babar Azam moves to fourth spot in T20I rankings, Suryakumar Yadav continues to be at top
01st May 2024WE RECOMMEND
Close to 100 schools in Delhi-NCR get bomb threat mails. Who sent the mails? What is the truth?
According to Delhi Police, the bomb threats sent via email to schools originated from Russia, as indicated by the IP address of the email, which was traced back to the domain "mail.ru"
01st May 2024Multiple schools across Delhi-NCR receive bomb threat, students evacuated; Delhi Police begin probe
Bomb detection teams, bomb disposal squads and officials of Delhi Fire Service have been rushed to schools and search operations are underway, a police officer said.
01st May 2024Delhi HC directs government to frame policy for compensating deaths due to Chinese ‘manjha’
In 2017, the Chinese Manjha was banned by the Indian government.
01st May 2024Licence of 14 Patanjali products cancelled. Check details here
In an affidavit filed in the Supreme Court, the licencing body said that it had suspended licenses of 14 products manufactured by Patanjali's Divya Pharmacy in connection with the misleading advertisements case.
30th April 2024Delhi Police summons Telangana CM Revanth Reddy in Amit Shah fake video case
The Congress leader has been asked to appear before Delhi Police's IFSO unit (Cyber Unit) on May 1 with his mobile phone.
29th April 2024